BMB Reports

생화학분자생물학회 (Korean Society for Biochemistry and Molecular Biology)
권호 표지
DOI QR코드

DOI QR Code

Investigation of the effect of SRSF9 overexpression on HIV-1 production

  • Ga-Na, Kim (Department of Pathology, National Research Laboratory for Molecular Virology, College of Medicine, The Catholic University of Korea) ;
  • Kyung-Lee, Yu (Department of Pathology, National Research Laboratory for Molecular Virology, College of Medicine, The Catholic University of Korea) ;
  • Hae-In, Kim (Department of Pathology, National Research Laboratory for Molecular Virology, College of Medicine, The Catholic University of Korea) ;
  • Ji Chang, You (Department of Pathology, National Research Laboratory for Molecular Virology, College of Medicine, The Catholic University of Korea)
  • 투고 : 2022.10.20
  • 심사 : 2022.11.02
  • 발행 : 2022.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Serine-arginine-rich splicing factors (SRSFs) are members of RNA processing proteins in the serine-arginine-rich (SR) family that could regulate the alternative splicing of the human immunodeficiency virus-1 (HIV-1). Whether SRSF9 has any effect on HIV-1 regulation requires elucidation. Here, we report for the first time the effects and mechanisms of SRSF9 on HIV-1 regulation. The overexpression of SRSF9 inhibits viral production and infectivity in both HEK293T and MT-4 cells. Deletion analysis of SRSF9 determined that the RNA regulation motif domain of SRSF9 is important for anti-HIV-1 effects. Furthermore, overexpression of SRSF9 increases multiple spliced forms of viral mRNA, such as Vpr mRNA. These data suggest that SRSF9 overexpression inhibits HIV-1 production by inducing the imbalanced HIV-1 mRNA splicing that could be exploited further for a novel HIV-1 therapeutic molecule.

키워드

과제정보

This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (2020R1F1A1075725, 2017R1A5A1015366 and 2020R1I1A1A01073574).

참고문헌

  1. Purcell DF and Martin MA (1993) Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 67, 6365-6378 https://doi.org/10.1128/jvi.67.11.6365-6378.1993
  2. Ocwieja KE, Sherrill-Mix S, Mukherjee R et al (2012) Dynamic regulation of HIV-1 mRNA populations analyzed by single-molecule enrichment and long-read sequencing. Nucleic Acids Res 40, 10345-10355 https://doi.org/10.1093/nar/gks753
  3. Tazi J, Bakkour N, Marchand V, Ayadi L, Aboufirassi A and Branlant C (2010) Alternative splicing: regulation of HIV-1 multiplication as a target for therapeutic action. Febs j 277, 867-876 https://doi.org/10.1111/j.1742-4658.2009.07522.x
  4. Klotman ME, Kim S, Buchbinder A, DeRossi A, Baltimore D and Wong-Staal F (1991) Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc Natl Acad Sci U S A 88, 5011-5015 https://doi.org/10.1073/pnas.88.11.5011
  5. Long JC and Caceres JF (2009) The SR protein family of splicing factors: master regulators of gene expression. Biochem J 417, 15-27 https://doi.org/10.1042/BJ20081501
  6. Anko ML (2014) Regulation of gene expression programmes by serine-arginine rich splicing factors. Semin Cell Dev Biol 32, 11-21 https://doi.org/10.1016/j.semcdb.2014.03.011
  7. Shepard PJ and Hertel KJ (2009) The SR protein family. Genome Biol 10, 242
  8. Mahiet C and Swanson CM (2016) Control of HIV-1 gene expression by SR proteins. Biochem Soc Trans 44, 1417-1425 https://doi.org/10.1042/BST20160113
  9. Stoltzfus CM and Madsen JM (2006) Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing. Curr HIV Res 4, 43-55 https://doi.org/10.2174/157016206775197655
  10. Ropers D, Ayadi L, Gattoni R et al (2004) Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA. J Biol Chem 279, 29963-29973 https://doi.org/10.1074/jbc.M404452200
  11. Erkelenz S, Hillebrand F, Widera M et al (2015) Balanced splicing at the Tat-specific HIV-1 3'ss A3 is critical for HIV-1 replication. Retrovirology 12, 29
  12. Exline CM, Feng Z and Stoltzfus CM (2008) Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression. J Virol 82, 3921-3931 https://doi.org/10.1128/JVI.01558-07
  13. Asang C, Hauber I and Schaal H (2008) Insights into the selective activation of alternatively used splice acceptors by the human immunodeficiency virus type-1 bidirectional splicing enhancer. Nucleic Acids Res 36, 1450-1463 https://doi.org/10.1093/nar/gkm1147
  14. Caputi M, Freund M, Kammler S, Asang C and Schaal H (2004) A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression. J Virol 78, 6517-6526 https://doi.org/10.1128/JVI.78.12.6517-6526.2004
  15. Jacquenet S, Decimo D, Muriaux D and Darlix JL (2005) Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production. Retrovirology 2, 33
  16. Somberg M, Li X, Johansson C et al (2011) Serine/arginine-rich protein 30c activates human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism. J Gen Virol 92, 2411-2421
  17. Dhanjal S, Kajitani N, Glahder J, Mossberg AK, Johansson C and Schwartz S (2015) Heterogeneous nuclear ribonucleoprotein C proteins interact with the human papillomavirus type 16 (HPV16) early 3'-untranslated region and alleviate suppression of HPV16 late L1 mRNA splicing. J Biol Chem 290, 13354-13371 https://doi.org/10.1074/jbc.M115.638098
  18. Makwaga O, Mulama DH, Muoma J and Mwau M (2021) Correlation of HIV-1 drug resistant mutations and virologic failure. Pan Afr Med J 39, 180
  19. Dlamini Z and Hull R (2017) Can the HIV-1 splicing machinery be targeted for drug discovery? HIV AIDS (Auckl) 9, 63-75 https://doi.org/10.2147/HIV.S120576
  20. Ji X, Zhou Y, Pandit S et al (2013) SR proteins collaborate with 7SK and promoter-associated nascent RNA to release paused polymerase. Cell 153, 855-868 https://doi.org/10.1016/j.cell.2013.04.028
  21. Paz S, Krainer AR and Caputi M (2014) HIV-1 transcription is regulated by splicing factor SRSF1. Nucleic Acids Res 42, 13812-13823 https://doi.org/10.1093/nar/gku1170
  22. Caceres JF, Screaton GR and Krainer AR (1998) A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev 12, 55-66 https://doi.org/10.1101/gad.12.1.55
  23. Swanson CM, Sherer NM and Malim MH (2010) SRp40 and SRp55 promote the translation of unspliced human immunodeficiency virus type 1 RNA. J Virol 84, 6748-6759 https://doi.org/10.1128/JVI.02526-09
  24. Swartz JE, Bor YC, Misawa Y, Rekosh D and Hammarskjold ML (2007) The shuttling SR protein 9G8 plays a role in translation of unspliced mRNA containing a constitutive transport element. J Biol Chem 282, 19844-19853 https://doi.org/10.1074/jbc.M701660200
  25. Wong RW, Balachandran A, Ostrowski MA and Cochrane A (2013) Digoxin suppresses HIV-1 replication by altering viral RNA processing. PLoS Pathog 9, e1003241
  26. Jablonski JA and Caputi M (2009) Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity. J Virol 83, 981-992 https://doi.org/10.1128/JVI.01801-08
  27. Weber J (2001) The pathogenesis of HIV-1 infection. Br Med Bull 58, 61-72
  28. Zhou Z and Fu XD (2013) Regulation of splicing by SR proteins and SR protein-specific kinases. Chromosoma 122, 191-207 https://doi.org/10.1007/s00412-013-0407-z
  29. Jeong S (2017) SR proteins: binders, regulators, and connectors of RNA. Mol Cells 40, 1-9 https://doi.org/10.14348/molcells.2017.2319
  30. Das S and Krainer AR (2014) Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer. Mol Cancer Res 12, 1195-1204 https://doi.org/10.1158/1541-7786.MCR-14-0131
  31. Paz S, Lu ML, Takata H, Trautmann L and Caputi M (2015) SRSF1 RNA recognition motifs are strong inhibitors of HIV-1 replication. J Virol 89, 6275-6286 https://doi.org/10.1128/JVI.00693-15
  32. Tacke R and Manley JL (1995) The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J 14, 3540-3551 https://doi.org/10.1002/j.1460-2075.1995.tb07360.x
  33. Sliskovic I, Eich H and Muller-McNicoll M (2022) Exploring the multifunctionality of SR proteins. Biochem Soc Trans 50, 187-198 https://doi.org/10.1042/BST20210325